Photobiomodulation: Hacking The Brain With Light & Lasers
Robert Sullivan
Robert Sullivan is a progressive Podiatry Clinician who holds a BSc(Hons) Podiatry, MSc Podiatric Surgery (Edinburgh) and of extended scope qualification including, acupuncture, mesotherapy, neuroscience and laser applications. Over the last 18 years he has lectured at Continued Professional Development events in Ireland, the United Kingdom, Europe and the United States. He has also been guest lecturer at various universities in Ireland, the UK and Europe. Robert has published papers in a number of medical journals both nationally and internationally and his recent paper on Low Level Laser Therapy in the treatment of Onychomycosis (2014) has been published in numerous languages. Robert also carries out surgical and none surgical demonstrations at clinical events and specialist educational seminars. His special Interests are, low level laser therapy, achieving your full potential, rheumatology and biomechanics. Mr Sullivan has worked for many years in the fields of cold laser medicine; his experience includes advanced education and support in body sculpting, fat loss, pain management, and brain stimulation via LLLT. Mr Sullivan’s clinical practice has changed dramatically over the last 3-5 years. Mr Sullivan enjoys and believes in sharing the knowledge for a better future. His current research includes, Lasers in viral management (HPV), LLLT for nerve regeneration in health crisis management, Brain laser techniques for a better you.
Laser, we all know what it stands for and we understand what it can do. Laser is; Light Amplification by Stimulated Emission of Radiation. What if its more than that? Life Advanced by Structured Enhanced Rejuvenation. This session examines, through audience participation, the possibilities of low level laser therapy when applied directly to the brain.
Once we have people like you and me looking at lasers, we have the ability to change the future. From a human recharge point of view, we haven't even started yet.
Summary
- Lasers target mitochondria to trigger a photochemical cascade, converting ADP to ATP and exciting cells to create a three-dimensional healing response throughout the system. - Unlike LEDs, true medical lasers must be collimated, monochromatic, and in phase to effectively penetrate cells and trigger specific biological responses. - This technology can significantly reduce acute or chronic pain in minutes and has shown remarkable results in managing conditions like concussion, Alzheimer’s, and Parkinson’s. - Research suggests limiting brain-targeted laser application to two minutes to avoid over-flooding the system once the desired biochemical changes have been triggered. - By stimulating cellular proliferation and increasing mitochondrial count, laser therapy may help mitigate the aging process and support long-term physical recovery and longevity.
Article
Light Against The Dark: How Robert Sullivan Framed Lasers As The Next Frontier In Human Repair
At Biohacker Summit 2018 Stockholm, A Podiatry Clinician Offered A Provocation As Much As A Presentation
In a conference culture that often lives somewhere between laboratory promise and wellness evangelism, Robert Sullivan arrived at Biohacker Summit 2018 Stockholm with a message designed to cut cleanly through the noise. His presentation, *Photobiomodulation: Hacking The Brain With Light & Lasers*, was not merely a sales pitch for a futuristic therapy. It was a claim about medicine itself: that coherent light, precisely delivered, might alter pain, brain function and recovery more quickly, and more fundamentally, than many conventional interventions.
Sullivan, a clinician with long experience in podiatry, surgery, neuroscience, acupuncture and laser applications, spoke on 18 May 2018 in Stockholm, Sweden, with the ease of a man who had spent years translating technical science into practical clinical language. He was also careful to root his case in a particular vocabulary: mitochondria, cytochrome C, ATP, photochemical cascades. This was not, he insisted, just light. It was mechanism.
The Core Argument Was Simple: The Laser Did Not Heal, It Triggered
At the centre of Sullivan’s talk was a distinction he returned to repeatedly. The laser itself, he argued, was not the cure. It was the spark.
“The laser triggers a photochemical response, and it is that response that changes things,” he said.
According to Sullivan, FDA-cleared 635 nanometre lasers could penetrate tissue deeply enough to reach cellular mitochondria, where they interacted with cytochrome C and helped drive the conversion of ADP to ATP. In his account, this biochemical shift excited cells, encouraged a three-dimensional cascade across neighbouring structures, and effectively recharged biological function from within.
It was, in his telling, less a blunt instrument than a switch.
That framing mattered, because Sullivan wanted to move photobiomodulation away from the language of gadgetry and into the language of systems biology. The point was not that the beam itself magically cured disease. The point was that light could set off a reaction the body already knew how to use.
Why Lasers, Not LEDs
Sullivan drew a hard line between medical lasers and the broader market of light-based devices that often blur into one another in public conversation. LEDs, he said, might emit light, but they were not the same as a true laser. To qualify, he argued, the light had to be collimated, monochromatic and in phase.
That distinction was more than technical snobbery. For Sullivan, it explained efficacy.
Unlike diffuse light, monochromatic coherent beams could produce the kind of targeted biological response he believed was necessary for meaningful therapeutic outcomes. In his account, lasers stimulated cellular proliferation and mitochondrial growth in ways ordinary LEDs could not reliably match.
The implication was clear: in an age eager for simple consumer-friendly interventions, Sullivan was making the case for precision over trend.
The Promise Was Immediate Relief, Not Just Long-Term Theory
If the science gave the talk its skeleton, demonstration gave it pulse.
Sullivan moved quickly from mitochondrial theory to outcomes that felt almost provocatively tangible. Pain, he said, could sometimes be lessened in under three minutes.
“With lasers, you can take someone in pain and change that pain or considerably lessen it in less than three minutes because of the effects of light and the chemical cascade,” he told the room.
That was the sort of line guaranteed to sharpen attention. It also reflected the larger emotional current of the session: a recurring effort to show that photobiomodulation was not only a concept for future medicine, but a tool that might already be changing lives at the level patients care about most, namely pain, clarity and function.
Live Demonstrations Turned Theory Into Theatre
Conference demonstrations often risk embarrassment, and this one flirted with it. Sullivan invited volunteers from the audience, one describing persistent stomach pain and confusion, another dealing with post-concussion headaches. What followed was part clinic, part showmanship.
He questioned each participant, applied the laser protocol, and narrated as he went. There were jokes, improvisations and enough uncertainty to keep the room from feeling scripted. But there were also reported shifts.
The volunteer with concussion-related headaches described the pain as no longer present by the end of the intervention. Another participant reported at least some reduction in stomach discomfort, moving from roughly a three to closer to a one or two on a subjective scale.
In a stricter scientific setting, such moments would prove very little on their own. They were anecdotal, public and inherently vulnerable to suggestion, expectation and performance pressure. Yet that was not really the point of the exercise. The point was rhetorical and experiential. Sullivan wanted the audience to see that whatever one believed about the limits of laser therapy, he was willing to put it to work in real time.
A Former Skeptic Made The Case More Forcefully Than A Believer Might Have
One of the most arresting details in the session was Sullivan’s own conversion story. He presented himself not as a natural acolyte of light medicine, but as someone who once set out to dismantle it.
He recalled being asked years earlier to validate a laser product whose research he considered weak. Offended by the claims, he and a group of PhD students set about deconstructing the devices, expecting to prove they were nonsense. Instead, he said, the process changed his mind.
That anecdote gave the talk a useful ballast. In the world of biohacking, where belief often races ahead of evidence, skepticism remains a form of authority. Sullivan understood that. By foregrounding his past doubt, he made his current conviction seem harder won, and therefore more persuasive.
The Deeper Challenge Was To Conventional Medicine
Sullivan’s most politically charged remarks came when he contrasted laser therapy with the older habits of clinical practice.
“Five years ago, I reached for a pen and wrote a prescription for a chemical. Now, I reach for a laser,” he said.
It was a line aimed squarely at modern medicine’s reflexes: medicate first, cut later, ask deeper questions only if both fail. In Sullivan’s framing, photobiomodulation offered something radically different, a non-invasive intervention that could reduce dependence on pharmaceuticals and perhaps postpone or replace more invasive procedures.
He also cast the struggle in adversarial terms, suggesting that drug companies had little interest in therapies that might disrupt established treatment models. Whether one accepts that framing in full or not, it illuminated the cultural mood of the room. This was not simply a discussion of one treatment modality. It was a broader insurgent argument about who gets to define the future of healthcare.
The Brain Became The Most Daring Frontier
For all the claims about pain relief and physical recovery, the most ambitious territory in Sullivan’s presentation was neurological. He spoke of experiments involving concussion, Alzheimer’s disease, Parkinson’s disease and autism, describing “remarkable changes” even after a single session.
Such claims sat at the edge of current public comfort, because they touched the organ most closely associated with identity itself. To suggest that light could affect the insular cortex, alter confusion, or rapidly shift chronic headache patterns was to suggest that targeted photobiomodulation might someday become a tool not just for rehabilitation but for cognitive modulation.
Sullivan urged caution here as well. In response to a question about overuse, he said his own research suggested limiting brain-directed application to two minutes. Beyond that point, he argued, the desired biochemical changes had already been triggered and additional exposure risked flooding the system without added benefit.
That note of restraint was telling. It suggested that even among enthusiasts, the appeal of the technology depended partly on acknowledging that more was not always better.
Recharging The Human Was Both A Slogan And A Philosophy
If one sentence captured the spirit of the presentation, it was this: “I think the thing we have to think about with lasers, from a biohacking point of view, is that this is how we recharge the human.”
It was a phrase made for a summit audience, concise enough to sound visionary, broad enough to mean almost everything. Yet Sullivan gave it personal weight. He spoke about living with chronic rheumatoid arthritis, using lasers on himself two or three times a week, taking no medicines and maintaining a high level of physical activity into his mid-fifties.
From there he widened the frame further. If laser therapy increased cellular proliferation and supported the growth of mitochondria, he suggested, then perhaps it might eventually intersect with the biology of ageing itself. He stopped short of grand certainty, but the implication was unmistakable: if energy production lies near the heart of decline, then manipulating it may become central to longevity science.
Between Evidence And Aspiration, A Field Revealed Its Ambitions
What Biohacker Summit 2018 Stockholm offered, through Robert Sullivan’s presentation, was not a settled verdict on photobiomodulation. It offered something more revealing: a snapshot of a field in the act of defining its ambitions.
There was confidence, certainly. At times there was evangelism. There were claims that would demand far more rigorous study before entering the mainstream unchallenged. But there was also a compelling idea at the centre of it all, one that continues to haunt modern medicine’s imagination: that the body might be nudged back toward function not only through chemistry and surgery, but through energy itself.
“I have yet, as a medical professional, to see something where we cannot affect a change with a laser,” Sullivan said.
That sentence may have sounded too absolute for skeptics, and too thrilling for believers to resist. But in Stockholm, on that May stage, its force lay less in whether it had been conclusively proved than in what it revealed about the future some clinicians were already trying to build: one in which light was not metaphor, but method.
Part of Biohacker Summit 2018 Stockholm